5 videos
| Date | Title | Duration | T | A | Summary Preview |
|---|---|---|---|---|---|
| Feb 18, 13:44 | Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) | N/A | — | — | No analysis |
| Feb 18, 09:59 | Itchy Skin Conditions? Novartis' Pivotal Trial Success Shows Potential For Targeted Relief | N/A | — | ✓ | === SUMMARY === - Novartis (NVS) announced positive topline results from its pivotal Phase 3 RemIND trial for the oral drug remibrutinib in chronic in... |
| Feb 18, 05:06 | Novartis Says Topline Results From Its Phase 3 RemIND Trial Of Oral Remibrutinib In Chronic Inducible Urticaria Met The Primary Endpoint, Achieving Significantly Higher Complete Response Rates Versus Placebo At Week 121 | N/A | — | — | No analysis |
| Feb 17, 13:00 | A Look Into Novartis Inc's Price Over Earnings | N/A | — | — | No analysis |
| Feb 13, 09:07 | Novartis Says Conditionally Approved Kidney Drug Shows Long-Term Promise | N/A | — | ✓ | # NVS News Report — 2026-02-14 ## Overview | Metric | Value | |--------|-------| | **Ticker** | NVS | | **Date** | 2026-02-14 | | **Total Articles**... |